Status:
COMPLETED
Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD
Lead Sponsor:
Unity Health Toronto
Conditions:
Real Function Post Conversion From Prograf to Advagraf
Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion
Eligibility:
All Genders
18-95 years
Brief Summary
In Kidney transplant recipients Once daily Tacrolimus has the poteb\]ntial advantage of better adnerence, and perhpas improvement in reanl function compred with the twice daily tacrolimus formulation....
Detailed Description
The Renal transplant program at St. Michael's is one of the largest in Canada. The CNI of choice since 2000 has been tacrolimus based therapy. In 2009 our program decided to switch from bid prograf to...
Eligibility Criteria
Inclusion
- Renal transplamnt recipients on prograf converted to advagraf
- \-
Exclusion
- none
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01884480
Start Date
June 1 2013
End Date
September 1 2014
Last Update
November 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St.Michael's Hospital
Toronto, Ontario, Canada, M5B1W8